Early PEG-Asparaginase Discontinuation in Young Adults With Acute Lymphoblastic Leukemia
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood Advances
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
The impact of early PEG-asparaginase discontinuation in young adults with ALL: A post hoc analysis of the C10403 study
Blood Adv 2022 Oct 21;[EPub Ahead of Print], I Aldoss, J Yin, A Wall, K Mrózek, M Liedtke, D Claxton, MC Foster, FR Appelbaum, HP Erba, MR Litzow, MS Tallman, RM Stone, RA Larson, AS Advani, W Stock, SM LugerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.